Health TrialsbyHealthPanel

The Relationship Between Gait and Severity of Femoroacetabular Impingement

ConditionFemoroacetabular Impingement
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorGazi University

About this trial

In this study, the spatiotemporal gait parameters of symptomatic femoroacetabular impingement (FAI) patients scheduled for hip arthroscopy are evaluated. Radiological measurements, including the Alpha angle (AA), Lateral Center-Edge Angle (LCEA), and Kellgren-Lawrence (KL) osteoarthritis classification, are recorded from patient files. The relationship between these radiological measurements and walking parameters is assessed. Additionally, the spatiotemporal gait parameters of FAI patients are compared with those of a healthy control group.

Walking assessments provide valuable insights into how Femoroacetabular Impingement (FAI) affects movement and aid in evaluating treatment outcomes. Research indicates that individuals with FAI experience reduced hip motion and slower walking speeds. By analyzing spatiotemporal gait parameters-such as gait velocity, cadence, step length, and vertical center of mass-the impact of FAI on walking can be better understood, leading to the development of targeted treatment strategies. The goal is to explore the correlation between these gait parameters and imaging-based FAI characteristics in affected individuals.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with femoroacetabular impingement scheduled for hip arthroscopy

Disqualifiers

Severe hip osteoarthritis

Hip dysplasia

Previous ipsilateral and/or contralateral hip surgery,

Any orthopedic or neurologic pathology that may affect gait patterns

Trial population

Patients scheduled for hip arthroscopy due to Femoroacetabular impingement syndrome at the Department of Orthopedics and Traumatology, Gazi University Faculty of Medicine, along with a healthy control group matched for age and gender, will be included in the study.

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • Walking assesment

    Other intervention

    Spatiotemporal walking assessments are performed using the Gait Analyzer app (version 0.9.95.0) on a smartphone. Participants who can walk independently without assistance walk a 25-meter path at their normal speed, with the smartphone securely attached to their body above the third lumbar vertebra using a belt. The app records gait velocity, cadence, step time, step length, and vertical center of mass for all participants.

Treatment groups

25 Participants
are divided into 2 treatment groups
Group A: Patient with Femoroacetabular Impingement1 intervention
Group B: Control group1 intervention

Trial outcomes

Primary outcomes

1

Gait velocity

Gait velocity, also known as walking speed, is a crucial parameter in spatiotemporal gait analysis. It refers to the rate at which an individual walks over a given distance and is typically measured in meters per second (m/s).

Time frame
Baseline
2

Cadence

Cadence refers to the number of steps a person takes per minute while walking.

Time frame
Baseline
3

Step length

Step length refers to the distance covered between two consecutive footfalls of opposite feet.

Time frame
Baseline
4

Vertical center of mass

The vertical center of mass refers to the vertical position of the body's center of mass during walking. It is the point where the body's mass is considered to be concentrated and it fluctuates as the person moves.

Time frame
Baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Gazi University

Lead sponsor

Source ClinicalTrials.gov
Apply now